摘要: |
[目的] 系统评价中医药治疗2型糖尿病合并抑郁的临床疗效与安全性。[方法] 计算机检索维普数据库、中国知网、万方数据库、中国生物医学文献数据库、Pubmed、Cochrace Library,纳入中医药治疗2型糖尿病合并抑郁的随机对照试验,检索时限均从建库至2015年12月,对纳入研究的资料进行评价,用RevMan 5.3软件进行分析。[结果] 共纳入符合要求的9篇文献,合计593例患者。Meta分析结果显示,与对照组相比,中医药治疗2型糖尿病合并抑郁在总有效率、用药后汉密尔顿(HAMD)评分变化:糖化血红蛋白(HbA1c)变化水平:不良反应方面具有一定的优势,差异均有统计学意义。[结论] 现有研究文献表明试验组对2型糖尿病合并抑郁在总有效率、HAMD、HbA1c变化方面优于对照组,同时在不良反应发生率方面,低于对照组。 |
关键词: 中医药 2型糖尿病 抑郁 临床疗效 系统评价 |
DOI:10.11656/j.issn.1673-9043.2016.06.05 |
分类号: |
基金项目:国家自然科学基金项目(81273914)。 |
|
Chinese medicine treatment of type 2 diabetes and depression evaluation system |
SHANG Cheng-ying1, CHANG Bai2, WEN Ying-ying1, HE Xia-xia1
|
1.Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;2.Metabolic Diseases Hospital, Tianjin Medical University, Tianjin 300070, China
|
Abstract: |
[Objective] To evaluate the safety and efficacy of the traditional Chinese medicine on depression in patients with type 2 diabetes mellitus.[Methods] All randomized controlled trials (RCTs) or quasi-randomized controlled trials from the database established to December 2015,It was searched on the VIP,CNKI,Wan fang,CBM,Pubmed,the Cochrane Liabrary about the traditional Chinese medicine on depression in patients with type 2 diabetes mellitus.And then Revman 5.3 was performed for meta-analyses.[Results] Nine trials including 593 cases were identified.Meta-analysis showed that:Compared with control group,the effective rate in The experimental group was higher than control group.Hamilton (HAMD) score changes:glycated hemoglobin (HbA1c) levels:adverse events were superior than normal group,the differences were statistically significant.[Conclusion] The existing research literature suggests that The effects of the traditional Chinese medicine on depression in patients with type 2 diabetes mellitus are better than Western medicine group,especially in the total efficiency,HAMD,HbA1c,and no severe adverse event was reported. |
Key words: Chinese medicine type 2 diabetes depression clinical efficacy systematic review |